Implications of the ISCHEMIA trial on the practice of surgical myocardial revascularization
Marc Ruel1, Louise Y Sun1, Michael E Farkouh2
1University of Ottawa Heart Institute, University of Ottawa, Ottawa, Ontario, Canada.
The Journal of Thoracic and Cardiovascular Surgery
|October 18, 2020
Abstract
No abstract available in PubMed .
Related Concept Videos
01:17Ischemic Heart Disease: Overview
2.5K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.5K
01:28Acute Coronary Syndrome IV: Interprofessional Care
128
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
128